BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25678504)

  • 1. Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.
    Fiorelli A; Accardo M; Carelli E; Angioletti D; Santini M; Di Domenico M
    Ann Thorac Surg; 2015 Jun; 99(6):1899-905. PubMed ID: 25678504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.
    Hofman V; Long E; Ilie M; Bonnetaud C; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Marquette CH; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Vielh P; Hofman P
    Cytopathology; 2012 Feb; 23(1):30-8. PubMed ID: 21210876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.
    Hofman VJ; Ilie MI; Bonnetaud C; Selva E; Long E; Molina T; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Butori C; Mourad N; Poudenx M; Bahadoran P; Sibon S; Guevara N; Santini J; Vénissac N; Mouroux J; Vielh P; Hofman PM
    Am J Clin Pathol; 2011 Jan; 135(1):146-56. PubMed ID: 21173137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer.
    Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsubota N; Tsujimura T; Tabata C; Nakano T; Hasegawa S
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):775-83. PubMed ID: 24618055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions.
    Darvishian F; Lin O
    Cancer; 2004 Dec; 102(6):355-61. PubMed ID: 15476290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of circulating stanniocalcin-1 mRNA in non-small cell lung cancer.
    Du YZ; Gu XH; Li L; Gao F
    J Surg Oncol; 2011 Dec; 104(7):836-40. PubMed ID: 21656524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
    Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
    Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interphase cytogenetics with DNA-probes for chromosome 8 to detect circulating tumor cells in breast cancer patients].
    Ghadimi BM; Uhr J; Tucker T; Heselmeyer-Haddad K; Auer G; Ried T; Becker H
    Zentralbl Chir; 2001 Nov; 126(11):922-5. PubMed ID: 11753805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
    Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer.
    Ren C; Chen H; Han C; Jin G; Wang D; Wang D; Tang D
    Med Hypotheses; 2013 Jun; 80(6):833-6. PubMed ID: 23587480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer].
    Dong Q; Feng J; Huang J; Bao G; Sha H; Gu W
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):142-6. PubMed ID: 12015035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytodiagnosis of 112 salivary gland lesions. Correlation with histologic and frozen section diagnosis.
    Chan MK; McGuire LJ; King W; Li AK; Lee JC
    Acta Cytol; 1992; 36(3):353-63. PubMed ID: 1580118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of microfluidic antibody-independent peripheral blood circulating tumor cell capture for the diagnosis of lung cancer.
    Lim E; Tay A; Von Der Thusen J; Freidin MB; Anikin V; Nicholson AG
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1936-8. PubMed ID: 24290574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
    Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
    Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.